BOC Sciences | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
Chemical manufacturer | ||||
chemBlink standard supplier since 2010 | ||||
Hangzhou Molcore Biopharmatech Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (571) 8102-5280 | |||
![]() |
sales@molcore.com | |||
![]() |
QQ chat | |||
Chemical manufacturer since 2010 | ||||
chemBlink standard supplier since 2017 | ||||
Anqing World Chemical Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 18155670904 | |||
![]() |
flint@worldpharma.cn | |||
![]() |
QQ chat | |||
Chemical distributor since 2010 | ||||
chemBlink standard supplier since 2021 | ||||
Wuhan Dingxintong Pharmaceutical Co., Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 15871722230 | |||
![]() |
15871722230@163.com | |||
![]() |
QQ chat | |||
Chemical distributor since 2019 | ||||
chemBlink standard supplier since 2023 | ||||
Targetmol China | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 (400) 820-0310 | |||
![]() |
sales@targetmol.cn | |||
Chemical manufacturer since 2015 | ||||
chemBlink standard supplier since 2025 | ||||
Classification | API >> Other chemicals |
---|---|
Name | (6R)-1,6-Dihydro-N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine hydrochloride |
Synonyms | (4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine;hydrochloride |
Molecular Structure | ![]() |
Molecular Formula | C6H13N5.x(HCl) |
CAS Registry Number | 775351-61-6 |
SMILES | C[C@@H]1N=C(NC(=N1)N(C)C)N.Cl |
Solubility | H2O: 2 mg/mL (Expl.) |
---|---|
Hazard Symbols |
|
---|---|
Hazard Statements | H302-H315-H319-H335 Details |
Precautionary Statements | P261-P305+P351+P338 Details |
SDS | Available |
(6R)-1,6-Dihydro-N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine hydrochloride is a chemical compound belonging to the class of triazine derivatives. The molecule features a 1,3,5-triazine ring, a six-membered heterocyclic system containing three nitrogen atoms at alternating positions. The designation (6R) specifies the absolute configuration at the chiral center located at the sixth position of the ring, indicating the spatial arrangement of the substituents in the molecule. This compound is characterized by methyl substitutions at the N2 and 6 positions, alongside diamine functionalities at the 2 and 4 positions of the triazine ring. The hydrochloride form indicates that the compound exists as a salt, with protonation occurring typically at the amino groups, which enhances its solubility and stability under various conditions. The discovery and synthesis of such triazine derivatives stem from the extensive research into heterocyclic compounds due to their broad biological and chemical significance. Triazine rings are well-known scaffolds in medicinal chemistry, agrochemicals, and materials science because they offer versatile chemical reactivity and the ability to engage in hydrogen bonding and other intermolecular interactions. Applications of (6R)-1,6-dihydro-N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine hydrochloride primarily relate to its potential use as a building block or intermediate in pharmaceutical and chemical synthesis. The structural features of this compound allow it to participate in reactions that yield more complex molecules, including drugs or functional materials. In medicinal chemistry, triazine derivatives have been studied for their antiviral, antibacterial, and anticancer properties. While specific biological activities of this exact compound are limited in well-established literature, its close structural relatives have shown bioactivity, making this compound of interest for further research and development. Additionally, the hydrochloride salt form facilitates its use in aqueous systems and biological assays, enabling studies of its interactions and effects in physiological conditions. In summary, (6R)-1,6-dihydro-N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine hydrochloride is a triazine-based compound characterized by specific methyl and amino substitutions and chiral configuration. It serves as a valuable intermediate in synthetic chemistry, with potential applications in pharmaceutical development and materials science due to the versatile chemistry of the triazine core. References 2020. Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment. Clinical Pharmacokinetics. DOI: 10.1007/s40262-020-00948-1 2021. Imeglimin Hydrochloride: First Approval. Drugs, 81(14). DOI: 10.1007/s40265-021-01589-9 2022. Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects. Clinical Drug Investigation, 42(8). DOI: 10.1007/s40261-022-01181-3 |
Market Analysis Reports |
List of Reports Available for (6R)-1,6-Dihydro-N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine hydrochloride |